Jim Collins is a Biopharmaceutical and medical device executive who focused on creation of innovative delivery devices that help people take their medicine as conveniently as possible.
He built two of the best delivery device development teams in the BioPharmaceutical industry at Eli Lilly and Sanofi. Using human centered design principles, he partnered with world class design, development, and manufacturing companies to ideate, develop, and launch multiple market leading delivery device technologies.
Key accomplishments include the creation at Lilly of market leading insulin KwikPen Platform, the Trulicity pen Platform, the Talz pen Platform, the Savvio Pen, the Forteo Pen, and many others. At Sanofi, multiple devices were developed for Toujeo, Soliqua, Praluent, Kevzara, and Dupixent including the development and launch of a number of first to market delivery systems including the first 2mL PFS safety system with BD, and the first to market 2mL autoinjector in partnership with SHL.
Currently, Jim is the Founder and President of Pharmaceutical Delivery Systems LLC, a company focused on drug delivery device consulting, a member of the Board of Directors of Enable Injections, a large volume delivery company, and the Board of Directors of Aktiv Medical Systems, a gas powered autoinjector company.